Macquarie Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.8M Sell
40,260
-20,339
-34% -$11M 0.12% 156
2025
Q4
$35.1M Sell
60,599
-293,036
-83% -$166M 0.15% 118
2025
Q3
$172M Sell
353,635
-82,699
-19% -$38.5M 0.2% 88
2025
Q2
$177M Buy
436,334
+291,758
+202% +$122M 0.22% 85
2025
Q1
$71.9M Buy
144,576
+10,890
+8% +$5.9M 0.09% 317
2024
Q4
$61.8M Sell
133,686
-85,723
-39% -$47.1M 0.08% 361
2024
Q3
$136M Buy
219,409
+89,586
+69% +$53M 0.15% 185
2024
Q2
$71.8M Sell
129,823
-808
-0.6% -$463K 0.08% 314
2024
Q1
$75.9M Sell
130,631
-3,469
-3% -$1.95M 0.09% 297
2023
Q4
$71.2M Sell
134,100
-20,092
-13% -$9.73M 0.08% 335
2023
Q3
$78M Buy
154,192
+19,799
+15% +$10.6M 0.1% 276
2023
Q2
$70.1M Sell
134,393
-21,608
-14% -$11.7M 0.08% 331
2023
Q1
$89.9M Sell
156,001
-55,053
-26% -$31M 0.11% 257
2022
Q4
$116M Sell
211,054
-163
-0.1% -$86.4K 0.14% 201
2022
Q3
$107M Sell
211,217
-15,273
-7% -$8.55M 0.13% 207
2022
Q2
$123M Sell
226,490
-71,632
-24% -$39.4M 0.14% 185
2022
Q1
$176K Buy
298,122
+75,455
+34% +$43.3M 0.13% 160
2021
Q4
$149M Sell
222,667
-6,936
-3% -$4.33M 0.12% 212
2021
Q3
$131M Sell
229,603
-17,454
-7% -$9.58M 0.11% 240
2021
Q2
$125M Buy
247,057
+66,021
+36% +$31.2M 0.1% 252
2021
Q1
$82.6M Sell
181,036
-15,871
-8% -$7.58M 0.12% 209
2020
Q4
$91.7M Buy
196,907
+23,496
+14% +$11M 0.13% 167
2020
Q3
$76.6M Sell
173,411
-4,509
-3% -$1.86M 0.13% 164
2020
Q2
$64.5M Sell
177,920
-3,723
-2% -$1.25M 0.11% 202
2020
Q1
$51.5M Sell
181,643
-27,322
-13% -$8.62M 0.11% 202
2019
Q4
$67.9M Buy
208,965
+23,308
+13% +$7.07M 0.1% 218
2019
Q3
$54.1M Buy
185,657
+1,481
+0.8% +$424K 0.09% 237
2019
Q2
$54.1M Buy
184,176
+908
+0.5% +$250K 0.09% 242
2019
Q1
$50.2M Sell
183,268
-6,546
-3% -$1.63M 0.09% 249
2018
Q4
$42.5M Sell
189,814
-12,009
-6% -$2.82M 0.08% 258
2018
Q3
$49.3M Sell
201,823
-10,315
-5% -$2.37M 0.08% 264
2018
Q2
$43.9M Sell
212,138
-3,174
-1% -$674K 0.08% 277
2018
Q1
$44.5M Buy
215,312
+715
+0.3% +$150K 0.08% 255
2017
Q4
$40.4M Buy
214,597
+46,239
+27% +$8.86M 0.07% 275
2017
Q3
$31.9M Buy
168,358
+7,296
+5% +$1.32M 0.06% 340
2017
Q2
$28.1M Buy
161,062
+8,953
+6% +$1.5M 0.05% 357
2017
Q1
$23.4M Sell
152,109
-31,908
-17% -$4.88M 0.04% 418
2016
Q4
$26M Sell
184,017
-81,886
-31% -$12.1M 0.05% 359
2016
Q3
$42.3M Sell
265,903
-307,353
-54% -$47.4M 0.08% 213
2016
Q2
$84.7M Buy
573,256
+254,007
+80% +$37.5M 0.08% 200
2016
Q1
$45.2M Sell
319,249
-23,266
-7% -$3.12M 0.09% 187
2015
Q4
$48.6M Buy
342,515
+30,770
+10% +$4.1M 0.1% 182
2015
Q3
$38.1M Sell
311,745
-6,450
-2% -$840K 0.08% 216
2015
Q2
$41.3M Sell
318,195
-128,577
-29% -$16.8M 0.08% 223
2015
Q1
$60M Sell
446,772
-16,407
-4% -$2.12M 0.12% 159
2014
Q4
$58M Sell
463,179
-14,936
-3% -$1.82M 0.12% 160
2014
Q3
$58.2M Buy
478,115
+8,091
+2% +$984K 0.12% 153
2014
Q2
$55.5M Buy
470,024
+21,158
+5% +$2.49M 0.12% 157
2014
Q1
$54M Sell
448,866
-42,190
-9% -$5.02M 0.09% 156
2013
Q4
$54.7M Buy
491,056
+5,665
+1% +$563K 0.1% 150
2013
Q3
$44.7M Sell
485,391
-27,829
-5% -$2.52M 0.09% 173
2013
Q2
$43.4M Buy
+513,220
New +$42.7M 0.09% 172

Other funds holding TMO

Macquarie Group's TMO Position: Q1 2026 in Review

Macquarie Group reduced its Thermo Fisher Scientific (TMO) stake by 34% in Q1 2026, selling an estimated $11M and leaving 40,260 shares worth $19.8M. The position accounts for 0.12% of the portfolio, ranked #156.

Macquarie Group first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $177M in Q2 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Macquarie Group held 40,260 shares of Thermo Fisher Scientific worth $19.8M as of Q1 2026.
  • Macquarie Group sold 20,339 Thermo Fisher Scientific shares in Q1 2026, an estimated $11M.
  • Thermo Fisher Scientific made up 0.12% of Macquarie Group's portfolio in Q1 2026, its #156 holding.
  • Macquarie Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Macquarie Group's Thermo Fisher Scientific position peaked at $177M in Q2 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.